Mould remediation in a home with an elderly or immunocompromised resident requires a higher standard of care than remediation in a property where all occupants are healthy adults. The process is similar, but the margin for error is smaller, the need for temporary relocation is greater, and the post-remediation confirmation standard is more demanding.
This guide covers what changes when a medically vulnerable person lives in a mould-affected home, for family members managing the situation, for property managers dealing with vulnerable tenants, and for anyone arranging remediation in these circumstances.
Who Is at Elevated Risk?
The following groups face meaningfully higher risk from mould exposure than healthy adults, particularly from species that cause invasive fungal infection:
Elderly residents (75+): Age-related immune decline (immunosenescence) reduces the effectiveness of innate and adaptive immune responses. Elderly people are more susceptible to respiratory infections generally, and fungal respiratory infections specifically. Pre-existing respiratory conditions (COPD, bronchiectasis, post-TB lung damage) are common in this age group and dramatically increase mould sensitivity.
Haematology patients: People undergoing chemotherapy or radiation for blood cancers (leukaemia, lymphoma), or following bone marrow transplant, are profoundly immunosuppressed. Aspergillus fumigatus is a life-threatening pathogen for this group, invasive aspergillosis has a mortality rate of 30-60% in haematology patients even with antifungal treatment. These patients should not be in a mould-affected home.
Solid organ transplant recipients: Post-transplant immunosuppression to prevent rejection creates significant vulnerability to opportunistic fungal infection. Risk persists for the life of the transplant.
HIV/AIDS with low CD4 count: Advanced HIV creates susceptibility to Cryptococcus neoformans and Aspergillus. With effective antiretroviral treatment, most HIV-positive people maintain CD4 counts that limit this risk, but those with advanced disease are genuinely at risk.
Autoimmune disease on immunosuppressants: Methotrexate, azathioprine, mycophenolate, biologics (anti-TNF, rituximab) used for rheumatoid arthritis, lupus, IBD and other conditions suppress immune function in ways that increase fungal infection risk.
Severe asthma and ABPA: Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity disorder driven by Aspergillus. For people with ABPA or severe fungal-sensitive asthma, even low mould concentrations can trigger severe exacerbations.
How the Risk Assessment Changes
For healthy adults, the threshold for urgent action is moderate-to-severe mould (significant surface area, multiple rooms, structural involvement). For immunocompromised residents, even small areas of mould in living spaces, particularly species like Aspergillus and Stachybotrys, warrant urgent response.
Species identification matters more. For healthy adults, we typically don’t differentiate strongly between Cladosporium (very common, low risk) and Aspergillus in recommending treatment urgency. For an immunocompromised resident, Aspergillus in any location is an urgent situation requiring immediate action and likely temporary relocation during remediation.
Temporary relocation threshold is lower. Healthy adults can often remain in the property during remediation with appropriate containment and ventilation. Immunocompromised residents should vacate before remediation begins and not return until post-remediation clearance testing confirms the property is clear. There is no room for gradual exposure as the spore count reduces during work.
Planning the Remediation
Pre-Work: Medical Team Communication
Where possible, consult the resident’s medical team before remediation commences. The treating physician or clinical team should know that:
- The patient has been or is being removed from a mould-affected environment
- Remediation is being carried out
- Post-remediation clearance testing will be conducted
- A return timeline is being established
This consultation allows the medical team to schedule any heightened monitoring, confirm whether the patient needs prophylactic antifungal treatment during any exposure period, and provide guidance on safe reoccupation standards.
Temporary Accommodation
Temporary accommodation for vulnerable residents during remediation requires:
- Clean, low-mould-risk environment (not another damp, older property)
- Location accessible to medical appointments if needed
- Duration planning: allow for the remediation period plus clearance testing turnaround time (typically 3-7 days after work)
If the resident is receiving home care services, notify the care provider of the temporary address change and any implications for service delivery.
Communication with Family and Carers
Family members and regular carers should be informed about:
- The nature of the mould problem
- The remediation plan and timeline
- The signs of mould-related health deterioration to watch for in the resident
- Who to contact if concerns arise during the remediation period
Enhanced Containment Standards
For remediation in properties with immunocompromised residents, containment standards should be at the highest appropriate level:
- Full plastic sheeting containment of affected areas with proper taped seals at edges
- Negative air pressure in work zones (HEPA-filtered negative air machines exhausting outside)
- AIIR (airborne infection isolation room) principles where the nature of the work warrants
- Full PPE for all workers in affected areas
- HEPA vacuuming before any treatments
The goal is zero spore dispersal from the work zone into the rest of the property. Containment that is adequate for a healthy adult household may need upgrading for a property with an immunocompromised resident.
Post-Remediation: Higher Clearance Standard
Standard post-remediation clearance testing compares indoor spore counts to outdoor baseline counts and expects indoor counts to be at or below outdoor levels, with no significant elevation of indicator species. For immunocompromised residents, this standard can be tightened:
- Request quantification of Aspergillus specifically alongside total spore counts
- Clearance testing should occur after full ventilation (24-48 hours), not immediately after work
- Consider a second clearance test if the first results are near the borderline
- Do not return the resident until clearance is definitively confirmed
Post-remediation measures:
Run HEPA air purifiers in the resident’s primary rooms, bedroom, main living area, for at least 2-4 weeks after remediation. This provides an additional layer of ongoing spore count reduction. Medical-grade HEPA units (H13 or H14 standard) are preferred.
Review ventilation of the property to prevent recontamination. A home that supported significant mould growth before remediation will do so again unless the moisture and ventilation conditions change.
Ongoing Monitoring
After remediation and return to the property, establish an ongoing monitoring schedule:
- Monthly visual inspection of all previously affected areas
- Three-month inspection by a professional if significant mould was present
- Immediate professional assessment if any mould smell or visible growth appears
Residents on significant immunosuppression may benefit from having a HEPA purifier running permanently in sleeping areas, this is a small, ongoing cost that provides meaningful risk reduction.
Frequently Asked Questions
My elderly parent with COPD lives in a rental with mould, what can I do urgently? If mould is affecting living areas and the resident is medically vulnerable, contact the landlord or property manager immediately in writing, citing the health risk and requesting urgent remediation. Under the NSW RTA, urgent repairs affecting health must be attended to promptly. Simultaneously, consult the resident’s GP about whether temporary relocation is warranted during the remediation process. If the landlord does not respond urgently, Fair Trading can be contacted.
Can a person on chemotherapy stay in a home while mould remediation is happening? No, we strongly advise against it. The remediation process disturbs mould, temporarily increasing airborne spore concentrations even with containment. For a person on active chemotherapy, even short-term elevated Aspergillus exposure creates serious infection risk. Full relocation during work is necessary.
What type of HEPA purifier should I get for an immunocompromised resident? Look for units with H13 or H14 HEPA filtration (tested to remove 99.95-99.99% of 0.3-micron particles). The unit should be appropriately sized for the room, check the CADR (Clean Air Delivery Rate) rating against the room volume. Brands with AHAM-verified ratings provide reliable performance data. Budget $300-$800 for a quality unit.
How long after mould remediation before an immunocompromised person can return? Clearance testing turnaround time (typically 3-7 days for laboratory results) plus the post-clearance ventilation period. Allow at minimum 10-14 days from completion of remediation to confident reoccupation. Medical clearance from the treating physician is recommended.
Our aged care facility has mould, what obligations apply? Aged care facilities are regulated by the Aged Care Quality and Safety Commission. Infection prevention and environmental health standards require that facilities be free from environmental hazards that pose infection risk. Mould in a residential aged care facility is a regulatory matter, report to the facility management and, if unresolved, to the ACQSC. The remediation standard for aged care settings is the clinical environment standard, not the residential standard.
Arranging mould remediation for a vulnerable resident in the Illawarra? Contact Illawarra Mould Removal, we adapt our protocols for medical sensitivity situations and work at the standard the situation requires.